USE OF ANTIBIOTICS IN THE PREPARATION OF CANINE KIDNEY TISSUE CULTURE VACCINES TO ELIMINATE LEPTOSPIRAL INFECTION HAZARDS.
D000818:Animals; D000900:Anti-Bacterial Agents; D000904:Antibiotics, Antitubercular; D001428:Bacterial Vaccines; D002701:Chloramphenicol; D003588:Cytopathogenic Effect, Viral; D004096:Dihydrostreptomycin Sulfate; D004283:Dog Diseases; D004285:Dogs; D007668:Kidney; D007919:Leptospira; D041341:Leptospira interrogans serovar canicola; D007922:Leptospirosis; D009355:Neomycin; D010406:Penicillins; D010600:Pharmacology; D011113:Polymyxins; D012106:Research; D013307:Streptomycin; D046509:Tissue Culture Techniques; D014357:Trypsin
D000900:Anti-Bacterial Agents; D000904:Antibiotics, Antitubercular; D001428:Bacterial Vaccines; D010406:Penicillins; D011113:Polymyxins; D002701:Chloramphenicol; D014357:Trypsin; D009355:Neomycin; D004096:Dihydrostreptomycin Sulfate; D013307:Streptomycin
ANTIBIOTICS; BACTERIAL VACCINES; CHLORAMPHENICOL; CYTOPATHOGENIC EFFECT, VIRAL; DOG DISEASES; EXPERIMENTAL LAB STUDY; LEPTOSPIRA CANICOLA; NEOMYCIN; PENICILLIN; PHARMACOLOGY; POLYMYXIN; STREPTOMYCIN; TISSUE CULTURE; TRYPSIN